Literature DB >> 23951467

GDF15 and AXII could be therapeutic targets in multiple myeloma.

.   

Abstract

Entities:  

Year:  2012        PMID： 23951467      PMCID： PMC3727790          DOI： 10.1038/bonekey.2012.74

Source DB:  PubMed          Journal:  Bonekey Rep        ISSN： 2047-6396


× No keyword cloud information.
  2 in total

1.  Bioactivity and prognostic significance of growth differentiation factor GDF15 secreted by bone marrow mesenchymal stem cells in multiple myeloma.

Authors:  Jill Corre; Elodie Labat; Nicolas Espagnolle; Benjamin Hébraud; Hervé Avet-Loiseau; Murielle Roussel; Anne Huynh; Mélanie Gadelorge; Pierre Cordelier; Bernard Klein; Philippe Moreau; Thierry Facon; Jean-Jacques Fournié; Michel Attal; Philippe Bourin
Journal:  Cancer Res       Date:  2012-02-02       Impact factor: 12.701

2.  Annexin II interactions with the annexin II receptor enhance multiple myeloma cell adhesion and growth in the bone marrow microenvironment.

Authors:  Sonia D'Souza; Noriyoshi Kurihara; Yusuke Shiozawa; Jeena Joseph; Russell Taichman; Deborah L Galson; G David Roodman
Journal:  Blood       Date:  2012-01-05       Impact factor: 22.113
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.